Neostigmine is used for reversing the adverse effect of:
**Core Concept**
Neostigmine is a cholinesterase inhibitor used to reverse non-depolarizing neuromuscular blockade. Non-depolarizing muscle relaxants, such as pancuronium, compete with acetylcholine for receptors at the neuromuscular junction, leading to muscle paralysis. Neostigmine works by inhibiting acetylcholinesterase, the enzyme responsible for breaking down acetylcholine, thereby increasing acetylcholine levels and overcoming the blockade.
**Why the Correct Answer is Right**
Neostigmine is effective in reversing the adverse effects of non-depolarizing muscle relaxants, such as pancuronium, when used in combination with drugs that increase acetylcholine levels, like d-tubocurarine (dTC). This is because neostigmine enhances the action of acetylcholine at the neuromuscular junction, counteracting the competitive blockade caused by non-depolarizing muscle relaxants. The combination of neostigmine and dTC is particularly effective in reversing muscle paralysis.
**Why Each Wrong Option is Incorrect**
**Option B:** dTC only is incorrect because neostigmine is not effective in reversing the effects of dTC alone, as dTC is a non-depolarizing muscle relaxant that works by competing with acetylcholine for receptors, and neostigmine only increases acetylcholine levels without overcoming the competitive blockade.
**Option C:** Alcuronium only is incorrect because alcuronium is a non-depolarizing muscle relaxant, and neostigmine is not specifically effective in reversing its effects. Alcuronium requires a different reversal agent, such as sugammadex.
**Option D:** Ketamine complication is incorrect because ketamine is an anesthetic agent that can cause various side effects, but neostigmine is not used to reverse ketamine-related complications. Neostigmine is specifically used to reverse non-depolarizing neuromuscular blockade.
**Clinical Pearl / High-Yield Fact**
When using neostigmine to reverse non-depolarizing neuromuscular blockade, it is essential to ensure that the patient has received a suitable non-depolarizing muscle relaxant, such as pancuronium, and that the reversal is performed in a timely manner to avoid prolonged paralysis.
**β Correct Answer: A. dTC + pancuronium**